芽生菌病中的细胞介导免疫保护作用。
Cell-mediated immunoprotection in blastomycosis.
作者信息
Cozad G C, Chang C T
出版信息
Infect Immun. 1980 May;28(2):398-403. doi: 10.1128/iai.28.2.398-403.1980.
Abstract
Delayed hypersensitivity can be induced in C57BL/6J mice by two subcutaneous injections of Merthiolate-killed Blastomyces dermatitidis yeast cells in Freund incomplete adjuvant. Development of delayed hypersensitivity peaked at the day 18 post-primary antigen-emulsion injection, as determined by footpad sensitivity tests. Mice rendered hypersensitive to B. dermatitidis were protected from the lethal effect of a blastomyces infection. The protection effects were shown both in mortality tests and in data from organ cultures as expressed by indices of resistance. Data from this study show that there is a close parallel relationship between host resistance and the prevailing level of delayed hypersensitivity.
摘要
通过在弗氏不完全佐剂中皮下注射两次硫柳汞灭活的皮炎芽生菌酵母细胞，可在C57BL/6J小鼠中诱导迟发型超敏反应。通过足垫敏感性试验确定，迟发型超敏反应在初次抗原乳剂注射后第18天达到峰值。对皮炎芽生菌产生超敏反应的小鼠可免受芽生菌感染的致死效应。在死亡率试验和器官培养数据中均显示出保护作用，以抗性指数表示。本研究数据表明，宿主抗性与迟发型超敏反应的流行水平之间存在密切的平行关系。
相似文献
1
Cell-mediated immunoprotection in blastomycosis.
Infect Immun. 1980 May;28(2):398-403. doi: 10.1128/iai.28.2.398-403.1980.
2
Role of delayed hypersensitivity in blastomycosis of mice.
Infect Immun. 1973 Mar;7(3):329-34. doi: 10.1128/iai.7.3.329-334.1973.
3
Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis.
Infect Immun. 1998 Nov;66(11):5443-9. doi: 10.1128/IAI.66.11.5443-5449.1998.
4
Protection against pulmonary blastomycosis: correlation with cellular and humoral immunity in mice after subcutaneous nonlethal infection.
Infect Immun. 1982 Aug;37(2):670-8. doi: 10.1128/iai.37.2.670-678.1982.
5
Passive transfer of delayed hypersensitivity to Blastomyces dermatitidis between mice.
Infect Immun. 1974 Oct;10(4):705-11. doi: 10.1128/iai.10.4.705-711.1974.
6
Thymosin restoration of cellular immunity to Blastomyces dermatitidis in T-cell-depleted mice.
Infect Immun. 1979 Oct;26(1):187-92. doi: 10.1128/iai.26.1.187-192.1979.
7
Evolution of inflammatory response and cellular immune responses in a murine model of disseminated blastomycosis.
Infect Immun. 1985 Oct;50(1):183-9. doi: 10.1128/iai.50.1.183-189.1985.
8
Detection of antibodies and delayed hypersensitivity with Rotofor preparative IEF fractions of Blastomyces dermatitidis yeast phase lysate antigen.
J Med Vet Mycol. 1995 Jul-Aug;33(4):209-14.
9
Immunoadjuvant effects of Blastomyces dermatitidis against EL 4 lymphoma in C57BL/6J mice.
J Natl Cancer Inst. 1982 Dec;69(6):1337-42.
10
Detection of antibodies and delayed dermal hypersensitivity with different lots of Blastomyces dermatitidis yeast lysate antigen: stability and specificity evaluations.
Mycoses. 1997 Nov;40(7-8):303-8. doi: 10.1111/j.1439-0507.1997.tb00236.x.
引用本文的文献
1
Host defence to pulmonary mycosis.
Can J Infect Dis. 1999 Mar;10(2):147-55. doi: 10.1155/1999/139326.
2
CD28 is required for optimal induction, but not maintenance, of vaccine-induced immunity to Blastomyces dermatitidis.
Infect Immun. 2005 Nov;73(11):7436-41. doi: 10.1128/IAI.73.11.7436-7441.2005.
3
Interleukin 12 as an adjuvant to WI-1 adhesin immunization augments delayed-type hypersensitivity, shifts the subclass distribution of immunoglobulin G antibodies, and enhances protective immunity to Blastomyces dermatitidis infection.
Infect Immun. 2000 Dec;68(12):7172-4. doi: 10.1128/IAI.68.12.7172-7174.2000.
4
T-Cell epitopes and human leukocyte antigen restriction elements of an immunodominant antigen of Blastomyces dermatitidis.
Infect Immun. 2000 Feb;68(2):502-10. doi: 10.1128/IAI.68.2.502-510.2000.
5
Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis.
Infect Immun. 1998 Nov;66(11):5443-9. doi: 10.1128/IAI.66.11.5443-5449.1998.
6
Protection against pulmonary blastomycosis: correlation with cellular and humoral immunity in mice after subcutaneous nonlethal infection.
Infect Immun. 1982 Aug;37(2):670-8. doi: 10.1128/iai.37.2.670-678.1982.
7
Blastomyces dermatitidis antigen-induced lymphocytes reactivity in human blastomycosis.
Infect Immun. 1981 Aug;33(2):485-90. doi: 10.1128/iai.33.2.485-490.1981.
8
Immunomodulation by Blastomyces dermatitidis: functional activity of murine peritoneal macrophages.
Infect Immun. 1983 May;40(2):733-40. doi: 10.1128/iai.40.2.733-740.1983.
9
Blastomycosis during pregnancy.
Can Med Assoc J. 1984 Oct 1;131(7):759-61.
10
In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism.
J Clin Invest. 1986 Aug;78(2):511-24. doi: 10.1172/JCI112603.
本文引用的文献
1
Resistance to reinfection in experimental histoplasmosis.
J Immunol. 1955 Mar;74(3):214-21.
2
IMMUNIZATION OF MICE TO COCCIDIOIDES IMMITIS: DOSE, REGIMEN AND SPHERULATION STAGE OF KILLED SPHERULE VACCINES.
J Immunol. 1965 Jan;94:132-42.
3
Specific and non-specific immunity in experimental cryptococcosis in mice.
J Exp Med. 1960 May 1;111(5):643-65. doi: 10.1084/jem.111.5.643.
4
Immunogenicity of spherule-endospore vaccines of Coccidioides immitis for mice.
J Immunol. 1961 Aug;87:218-27.
5
Immunization of mice with viable Cocidioides immitis.
J Immunol. 1961 Jan;86:28-34.
6
Some factors affecting resistance of mice to experimental histoplasmosis.
Proc Soc Exp Biol Med. 1954 Feb;85(2):223-5. doi: 10.3181/00379727-85-20837.
7
Nature of the skin-reactive principle in culture filtrates prepared from Paracoccidioides brasiliensis.
J Bacteriol. 1967 Jun;93(6):1741-8. doi: 10.1128/jb.93.6.1741-1748.1967.
8
9
Respiratory infection of mice with Histoplasma capsulatum.
Mycopathol Mycol Appl. 1965 Dec 1;27(3):305-10. doi: 10.1007/BF02053788.
10
The relationship of delayed hypersensitivity to acquired cellular resistance.
Br Med Bull. 1967 Jan;23(1):52-4. doi: 10.1093/oxfordjournals.bmb.a070516.
Zotero 插件